2020 Innovation Issue: Regenstrief’s half century of health innovations
The not-for-profit and its health research are a testament to the idea that all innovation is related—even when the connection appears tenuous at first glance.
Medical Research
Articles
IU team pursuing breathtaking advancements in regenerative medicine
The emerging health care field seeks to develop methods for replacing or reinvigorating damaged human organs, cells and tissues.
Researchers scour COVID-19 data to find peak
Health-data specialists at universities and research institutes in Indianapolis expect the virus to hit its peak between mid-April and early May, packing a punch that could cause about 800 new positive COVID-19 cases a day.
Lilly teams with Canadian biotech in race to find treatment for COVID-19
The Indianapolis-based drugmaker said it will combine its capability for quickly developing antibodies with AbCellera’s “rapid pandemic response platform,” with the goal of getting a treatment into clinics for human testing within four months.
Butler researchers point to way to stop deadly coronavirus from spreading
Dr. Christopher Stobart and his students are focusing on an enzyme in the virus that could inhibit its replication, and plan to submit the findings to a virology journal in coming months.
Ravi Parikh: Why for-profit research should be taken seriously
Patient data is increasingly in the hands of for-profit industries. Insurance firms and other for-profit companies have been collecting patient data that yields important information that could be used to shape medical care and health policy.
New scientific study reveals more about the power of snot
Mucus may be gross, but we produce a lot of it. And new research is uncovering just how beneficial it is in the human body.
Cook Regentec spins off first biotech from Indy-based incubator
The spinoff, called Sexton Biotechnologies, has raised $5 million in outside investment and will spin off in October. The biotech develops cell and gene therapy tools used to grow cells for medical purposes.
App’s success leads Don Brown to embrace consumer market
After building and selling three companies and starting a fourth, Dr. Don Brown thought he had seen it all. Even so, he still gets an occasional surprise.
Startup claims breakthrough in gauging pain
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
IBJ Podcast: This IU pediatrician is a health care myth buster
Should you avoid red meat? No. Should you strive for 10,000 steps a day? Not unless you just want to. So says Dr. Aaron Carroll, a pediatrician and researcher at the Indiana University School of Medicine who sees it as his life’s calling to debunk what he considers health myths and weak medical research.
Debunking medical myths all in a day’s work for IU’s Dr. Aaron Carroll
Carroll uses Twitter, a New York Times column, blog post, podcast, videos and books to publish his findings on just about any health issue he thinks needs explaining or correcting.
Lilly’s push into pain research starting to pay off
In recent months, the drugmaker has won federal approval to sell a drug called Emgality for two conditions: migraine pain and cluster headaches.
IU medical school part of genomics research
The trials, which will begin in 2020, are part of a sweeping, five-year, $42 million federal research program known as Implementing Genomics in Practice. The first trial will examine whether early access to patients’ genomic data can help with treatment of high blood pressure, hypertension and chronic kidney disease.
Indiana Biosciences Research Institute’s top exec steps down, citing health problems
Dr. Rainer Fischer is giving up the roles of CEO and chief scientific officer, but will continue as senior executive for innovation and discovery.
Indy startup Outpost Medicine draws in big money to develop drug therapies
For a startup that has raised an eye-popping $71 million in just three years, Outpost Medicine LLC likes to keep a low profile. The young company, which is developing drugs for urinary and gastrointestinal disorders, is headquartered in small, unmarked space at the Parkwood Crossing office complex on East 96th Street. It has issued only a […]
Harvard study involving Anthem unit finds older insulins are both safe, cheaper
Increasingly, top researchers are questioning whether drugs such as Lantus from Sanofi, Levemir and Novolog from Novo Nordisk A/S, and Humalog from Eli Lilly and Co. are really needed for many patients.
Two IU researchers win $2.3M grant to study neuropathy in cancer patients
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
Eli Lilly partner urges investors to look beyond biotech turmoil
Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.
Trump focusing on drug prices, high among voters’ concerns
President Donald Trump is linking the drug prices Americans complain about to one of his longstanding grievances: foreign countries the president says are taking advantage of U.S. research breakthroughs.